{"id":"W3047911379","doi":"10.1111/cas.14605","title":"Efficacy of local therapy for oligoprogressive disease after programmed cell death 1 blockade in advanced non‐small cell lung cancer","year":2020,"lang":"en","type":"article","venue":"Cancer Science","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":42,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"Chugai Pharmaceutical; Novartis Pharma; Merck Sharp and Dohme; Ono Pharmaceutical; Astellas Pharma; Daiichi Sankyo Company; Clovis Oncology; Astellas Pharma Canada; Taiho Pharmaceutical; Boehringer Ingelheim; Bristol-Myers Squibb; AstraZeneca; Pfizer; Takeda Pharmaceutical Company; AbbVie; Kyowa Hakko Kirin","keywords":"Pembrolizumab; Medicine; Nivolumab; Internal medicine; Oncology; Lung cancer; Retrospective cohort study; Progressive disease; Disease; Cancer; Immunotherapy","routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006905549,0.0001385126,0.0004627401,0.0002362595,0.0001362218,0.0002060697,0.0001326153,0.0001052174,0.000359405],"category_scores_gemma":[0.000783777,0.00005866993,0.0003654296,0.0001676385,0.0001870756,0.0001848468,0.0001436686,0.0002243468,0.00007663285],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002090941,"about_ca_system_score_gemma":0.0001410885,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002725207,"about_ca_topic_score_gemma":0.0009906362,"domain_scores_codex":[0.9997471,0.0001102697,0.00002983914,0.00003716124,0.00004434763,0.00003136933],"domain_scores_gemma":[0.9994131,0.0002151399,0.0001782207,0.00004216456,0.00003646611,0.0001148563],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.01708264,0.0009376713,0.7365868,0.0004300931,0.0007253063,0.001253984,0.0002059702,0.001768497,0.02734189,0.00008529492,0.0004920812,0.2130897],"study_design_scores_gemma":[0.0005931287,0.02766514,0.9612212,0.00006797783,0.0005096754,0.002111476,0.0001281505,0.001022721,0.005449831,0.00005521144,0.001161497,0.00001405671],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9965841,0.002937997,0.00009118936,0.0000140346,0.000004354099,0.00001048588,0.0000337767,0.000004914314,0.0003191043],"genre_scores_gemma":[0.9992262,0.0005295229,0.00005221007,0.00001928366,0.000009240426,0.000006981702,0.00008285519,0.000001059795,0.0000724834],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.0006905549,"threshold_uncertainty_score":0.003652036,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01732833794609896,"score_gpt":0.3128700621882125,"score_spread":0.2955417242421136,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}